| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |